Health Products

Teva-Triamterene/HCTZ (2020-07-24)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III

Summary

Product

Teva-Triamterene/HCTZ

Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameDIN, NPN, DIN-HIMDosage formStrength
35360453A
Recalling Firm
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Teva-Triamterene/HCTZDIN 00532657TabletTriamterene 50mg and Hydrochlorothiazide 25mg

Reason

The assay for Triamterene is out of specification in the affected lot and the assay for Hydrochlorothiazide (HCTZ) is out of trend in the affected lot.

Alternate Brand Names: Maxzide, Dyazide, Dyrenium

Depth of distribution

Wholesalers, Retailers
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime